Cancer Biomarker Testing Market Grows with Precision Oncology and Early Detection Demand | Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott

The global cancer biomarker testing market was valued at US$ 29.83 Billion in 2023. The market size reached US$ 33.37 Billion in 2024 and is expected to reach US$ 96.53 Billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

Cancer Biomarker Testing Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising adoption of precision oncology, demand for early detection, and advances in liquid biopsy and next-generation sequencing, the report delivers strategic insights for stakeholders in the molecular diagnostics sector from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cancer-biomarker-testing-market?ophp

This involves identifying genetic, protein, or cellular markers to guide cancer diagnosis, prognosis, and treatment decisions. The market is rapidly evolving due to increasing use in precision oncology, companion diagnostics, and liquid biopsy technologies. Biomarker testing enhances therapeutic targeting and treatment outcomes.

Cancer Biomarker Testing Market Competitors Overview:

Illumina, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, QIAGEN, Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Agilent Technologies, BioMérieux, and Foundation Medicine, Inc., among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In May 2025, Cizzle Bio, Inc., a biotechnology company specializing in innovative cancer diagnostics, agreed with Doctors Hospital in the Cayman Islands to provide its advanced blood-based tests for early cancer detection. Specifically, the hospital's clinical laboratory will now offer Cizzle Bio's CIZ1B lung cancer test and DEX-G2 gastric cancer test.

✅In February 2025, Imagene, a company specializing in artificial intelligence (AI) solutions for oncology, announced a collaboration with Tempus AI, Inc., a technology leader in AI-driven precision medicine. The goal of this partnership is to advance cancer diagnostics by leveraging the strengths of both companies in AI and clinical data.

Methodology and Scope

The Cancer Biomarker Testing Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cancer-biomarker-testing-market?ophp

Cancer Biomarker Testing Market Segments Overview:

∎ By Test Type (Genetic Biomarker Testing, Protein Biomarker Testing, Circulating Tumor DNA (ctDNA) Testing, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Others)
∎ By Product Type (Instruments (PCR Machines, NGS Platforms, Mass Spectrometers, ctDNA Detection Devices, Others), Kits & Reagents)
∎ By Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Leukemia, Others)
∎ By Application (Drug Discovery and Development, Disease Screening, Treatment Planning, Others)

The genetic (DNA-based) biomarkers segment leads due to its pivotal role in guiding targeted therapies, early diagnosis, and personalized treatment strategies across cancer types.

Regional Overview for Cancer Biomarker Testing Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America holds the lead, driven by precision medicine and biomarker-driven therapies. Asia Pacific is the fastest growing region due to increasing oncology diagnostics penetration.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cancer-biomarker-testing-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Cancer Biomarker Testing market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cancer Biomarker Testing market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.